C07 Compassionate use同情给药/Expanded access扩大使用/Pre-...
【例句1】Compassionate use is a term used to describe the provision of an unauthorized medicine when it is given to a patient at no cost.This usually occurs when a drug company recognizes there is a serious need for its product.It,therefore,creates a program to provide it free of charge to an individual patient or a group of patients.Companies running phase 2 or 3 clinical trials in the US,must have an Expanded Access Policy published on their website.The policy should explain whether the company has chosen to provide its investigational product(s)to patients on an expanded access(compassionate use)basis.The policy must include contact information which physicians can use to apply for a program or send questions.The policy must also explain how a company will review and respond to expanded access requests.(https://www.wepclinical.com/what-is-a-compassionate-useprogram/)
【译文1】“同情给药”这个术语用来描述当制药公司意识到人们对其产品有严重需求时,免费提供未经授权的药物给病人。因此,它创建了一个程序,免费提供给单个病人或一组病人。在美国进行2期或3期临床试验的公司必须在其网站上发布扩展访问政策,政策应解释公司是否选择在扩大获取(同情给药)的基础上向患者提供其研究性产品。该政策必须包括医生可以用来申请项目或发送问题的联系信息,还必须解释公司将如何审查和响应扩展访问请求。
【例句2】In China,Drug Administration Law of the People’s Republic of China(2019 Revision)provides for a compassionate drug system.Article 23 For drugs under clinical trial which are used for treatment of serious life-threatening diseases for which there is no effective treatment,where it is concluded from medical observation that such drugs are beneficial and comply with ethical principles,such drug may be used within the clinical trial institution on other patients with the same condition upon review by ethics committee and obtaining informed consent。(https://www.daowen.com)
【译文2】在中国,2019年修订的《中华人民共和国药品管理法》规定了同情给药制度。该法第二十三条规定,对正在开展临床试验的用于治疗严重危及生命且尚无有效治疗手段的疾病的药物,经医学观察可能获益,并且符合伦理原则的,经伦理委员会审查、并获得知情同意后可以在开展临床试验的机构内用于其他病情相同的患者。
【练习】The treatment options through a compassionate use program are for patients suffering from rare diseases,cancers,or other life-threatening conditions.Patients suffering from such a disease or condition will likely have no effective or approved treatment options available to them。